![James Hall](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
James Hall is Chief Executive Officer at Betagenon AB since 2021.
Formerly, Dr. Hall was Chief Executive Officer at Athera Biotechnologies AB from 2019 to 2021.
Dr. Hall also served as Chief Executive Officer at Amplifier TX AB.
| Empresas | Cargo | Inicio |
|---|---|---|
Balticgruppen Bio AB
 Balticgruppen Bio AB Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops activated protein kinase | Director Ejecutivo | 01/05/2021 |
| Empresas | Cargo | Fin |
|---|---|---|
Athera Biotechnologies AB
 Athera Biotechnologies AB Pharmaceuticals: MajorHealth Technology Provides anti-inflammatory biological candidate drugs | Director Ejecutivo | 01/04/2021 |
Amplifier TX AB
 Amplifier TX AB BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops clinical molecule AMPK activators | Director Ejecutivo | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
| Empresas privadas | 3 |
|---|---|
Athera Biotechnologies AB
Athera Biotechnologies AB Pharmaceuticals: MajorHealth Technology Provides anti-inflammatory biological candidate drugs | Health Technology |
Balticgruppen Bio AB
Balticgruppen Bio AB Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops activated protein kinase | Health Technology |
Amplifier TX AB
Amplifier TX AB BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops clinical molecule AMPK activators | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
